Publications
- Pharmacokinetics, efficacy and safety of IMMUNATE (R) Solvent/Detergent (IMMUNATE (R) S/D) in previously treated patients with severe hemophilia A: Results of a prospective, multicenter, open-label phase III study2008 | Second Faculty of Medicine
- Evaluation of pharmacokinetics, efficacy and safety of Immunate (R) solvent detergent in previously treated patients with severe haemophilia A2007 | Second Faculty of Medicine
- Severe congenital bleeding disorders manifesting in the neonatal period - case reports2022 | Second Faculty of Medicine
- Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with haemophilia, 3rd edition, year 20212021 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with congenital haemophilia and FVIII/ FIX inhibitors2021 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- A practical, one-clinic visit protocol for pharmacokinetic profile generation with the ADVATE(R) myPKFiT(R) dosing tool in severe hemophilia A subjects2021 | Second Faculty of Medicine
- octanate (R): over 20 years of clinical experience in overcoming challenges in haemophilia A treatment2020 | Second Faculty of Medicine
- Intracranial haemorrhage in patients with haemophilia A2019 | Second Faculty of Medicine
- New era of management of patients with haemophilia - replacement therapy with coagulation factors VIII and IX with an extended half-life (EHL)2019 | Second Faculty of Medicine
- Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate((R)): Final report from a prospective study2018 | Second Faculty of Medicine
Loading network view...